Previous studies suggest that PARP-1 overexpression is a potential novel biomarker of aggressive clinical behavior in cutaneous malignant melanoma [13], but there are no studies focused on the prognostic significance of PARP1 expression in mucosal melanoma patients. This evidence concerns the gene PARP1 and cutaneous melanoma.